Wolfe Repass plans sale of 13,796 shares (NASDAQ: FLD)

Rhea-AI Filing Summary

Wolfe Repass reported proposed sales of 13,796 common shares under Rule 144. The filing lists the securities as restricted stock vesting on 02/23/2026 and shows recent dispositions during February 2026, including 21,857, 12,406, and 4,179 shares sold on separate dates.

The securities are held at Fidelity Brokerage Services LLC and the filing identifies NASDAQ as the market. The filing appears to relate to compensation vesting and subsequent Rule 144 sale notices.

Insights

Securities Compliance Expert

Rule 144 notice documenting an issuer-related vesting and recent open-market dispositions.

The filing lists 13,796 common shares described in the "Securities To Be Sold" line and notes a 02/23/2026 restricted stock vesting event identified as compensation. It also itemizes three prior February 2026 dispositions of 21,857, 12,406, and 4,179 shares.

Timing and cash‑flow treatment are not detailed beyond the sale dates. Subsequent reports or broker confirmations would show actual sale proceeds and final transfer timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13796	20285.64	48307642	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			13796	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/19/2026	21857	32427.05
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/20/2026	12406	19179.67
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/23/2026	4179	6192.86

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does FLD's Form 144 disclose about the shares to be sold?

Answer: The Form 144 lists 13,796 common shares under the "Securities To Be Sold" line and identifies a restricted stock vesting on 02/23/2026. The filing ties the securities to compensation-related vesting.

How many FLD shares were sold by Wolfe Repass in February 2026?

Answer: The filing records three dispositions in February 2026: 21,857, 12,406, and 4,179 common shares on separate dates. These sales are shown in the "Securities Sold During The Past 3 Months" section.

Which brokerage and market are listed for the FLD shares?

Answer: The filing identifies Fidelity Brokerage Services LLC as the broker location and NASDAQ as the market. The broker address and exchange appear on the securities information line.

Is the Form 144 tied to compensation vesting for FLD?

Answer: Yes. The document shows a "Restricted Stock Vesting" entry dated 02/23/2026 with the issuer listed and the transaction type labeled Compensation, indicating the shares derive from a vesting event.